IB and the Mayo Clinic Enter into an Agreement to Develop IB Trax™
IQ-AI Limited (IQAI.L) Montgomery Cancer Center Purchases IB’s Software
Imaging Biometrics®, LLC (“IB”), a subsidiary of IQ-AI Limited (LON:IQAI), is pleased to announce that the Montgomery Cancer Center (Montgomery, Alabama, USA), has purchased IB Clinic.
IQ-AI Limited (IQAI.L) LSN Software Receives FDA Clearance
IQ-AI today announces that the US Food and Drug Administration (“FDA”) has granted 510(k) market clearance for the Liver Surface Nodularity (“LSN”) software application. Earlier this year, IQ-AI’s subsidiary, Imaging
IQ-AI Limited (LON:IQAI) FDA Clearance to Market for StoneChecker Software
IQ-AI Announce FDA ‘Clearance to Market’ For StoneChecker Software